GWM
EW icon

GDS Wealth Management’s Edwards Lifesciences EW Stock Holding History

GDS Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.1M Buy
266,372
+18,760
+8% +$1.57M 1.15% 34
2026
Q1 		$19.8M Buy
247,612
+14,736
+6% +$1.21M 1.19% 35
2025
Q4 		$19.9M Buy
232,876
+6,878
+3% +$564K 1.24% 28
2025
Q3 		$17.6M Buy
225,998
+9,046
+4% +$707K 1.16% 30
2025
Q2 		$17M Buy
216,952
+10,333
+5% +$771K 1.24% 30
2025
Q1 		$15M Buy
206,619
+15,606
+8% +$1.12M 1.28% 31
2024
Q4 		$14.1M Buy
191,013
+60,339
+46% +$4.22M 1.29% 37
2024
Q3 		$8.62M Sell
130,674
-63,717
-33% -$4.63M 0.84% 44
2024
Q2 		$18M Buy
194,391
+6,764
+4% +$599K 1.97% 16
2024
Q1 		$17.9M Buy
187,627
+5,418
+3% +$455K 2.1% 11
2023
Q4 		$13.9M Buy
182,209
+90,328
+98% +$6.29M 1.87% 16
2023
Q3 		$6.37M Buy
91,881
+8,323
+10% +$669K 1% 40
2023
Q2 		$7.88M Sell
83,558
-13,296
-14% -$1.16M 1.28% 25
2023
Q1 		$8.01M Buy
96,854
+14,259
+17% +$1.12M 1.42% 20
2022
Q4 		$6.16M Buy
82,595
+19,642
+31% +$1.51M 1.18% 34
2022
Q3 		$5.2M Buy
62,953
+2,391
+4% +$230K 1.16% 31
2022
Q2 		$5.76M Buy
60,562
+22,357
+59% +$2.31M 1.29% 31
2022
Q1 		$4.56M Buy
38,205
+2,144
+6% +$241K 1% 27
2021
Q4 		$4.67M Buy
+36,061
New +$4.21M 1.05% 26

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GDS Wealth Management's EW Position: Q2 2026 in Review

GDS Wealth Management increased its Edwards Lifesciences (EW) stake by 7.6% in Q2 2026, buying an estimated $1.57M and bringing the position to 266,372 shares worth $24.1M. The position accounts for 1.15% of the portfolio, ranked #34.

GDS Wealth Management first reported a position in EW in Q4 2021 and has held it in 19 quarters since. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • GDS Wealth Management held 266,372 shares of Edwards Lifesciences worth $24.1M as of Q2 2026.
  • GDS Wealth Management bought 18,760 Edwards Lifesciences shares in Q2 2026, an estimated $1.57M.
  • Edwards Lifesciences made up 1.15% of GDS Wealth Management's portfolio in Q2 2026, its #34 holding.
  • GDS Wealth Management first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on GDS Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.